Proteus Digital Health has received de novo FDA 510k clearance for its Ingestible Event Monitor medication adherence system after four year review.
Tag: Proteus Biomedical
Stratos Product Development LLC recently announced it is working with Proteus Biomedical to develop advanced mobile health technology to provide personalized therapy to users.
Greetings valued readers! This is the second installment of our bi-monthly summaries of our favorite posts (difficult to choose) as well as the posts we feel were best received by you, our readers. Our increase in the amount of information that we give to you means that you may not always have time to read everything we post in a given month. We are proud to be able to provide you quality app reviews and the latest mHealth news, so without further delay, here are our second round of favorite posts for February:
Gentag CEO John Peeters explains how Gentag is pioneering the future of body computing with zero power NFC sensors that are essentially disposable.
by Tim Bredrup Proteus Biomedical Inc., a pioneer in digital health, recently announced that the United States Patent Office will award US Patent Number 8114021 to Proteus. The patent, entitled “Body Associated Receiver and Method,” is directed to the Proteus wearable and ingestible sensor technologies and related sensor devices used to create digital communication networks […]
Smart pills with edible microchips are expected to be released in the UK capable of transmitting physiological data to smartphones or computers. That means the smart pills can remind patients of upcoming medication doses and even report back to their doctor when they have taken it. The system captures exactly what medications have been taken.